CUSIP: 192003101
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,501,627
-
Share change
-
-71,890
-
Total reported value
-
$15,090,057
-
Price per share
-
$1.22
-
Number of holders
-
23
-
Value change
-
-$152,819
-
Number of buys
-
10
-
Number of sells
-
13
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 192003101:
Institutional Holders of CODEX DNA INC - COM (TBIO) as of Q4 2022
As of 31 Dec 2022,
CODEX DNA INC - COM (TBIO) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,501,627 shares.
The largest 10 holders included
Northpond Ventures, LLC, Penn Capital Management Company, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Penbrook Management LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, and BlackRock Inc..
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.